Epithalon

Epithalon Nasal Spray is supplied as a catalogued research material in the exact format and strength: nasal spray, 10mg/10ml. This presentation identifies the catalogue formulation; it does not establish equivalence to materials described in published research.

Epithalon, also named Epitalon, denotes the synthetic AEDG tetrapeptide with the sequence Ala-Glu-Asp-Gly. It must not be confused with Epithalamin, a biologically derived pineal extract discussed in separate publications. The defined peptide and the compositionally complex extract are distinct research materials. Registry information below is conditional on confirmation of the exact molecular entity and batch form.

Chemical properties and registry information

Formula and molecular mass describe the specified peptide entity, not the complete spray formulation. Batch documentation takes precedence when identifying the supplied material.

Research background and published evidence

Published research

Published AEDG research includes an in-vitro investigation of telomerase activity and telomere length in cultured human fetal fibroblasts. This provides a defined cell-model research context. It does not constitute a study of this nasal spray, its excipients or its finished formulation. Publications concerning Epithalamin address a different preparation and must be evaluated separately.

Current scientific understanding

The evidence described here is limited by the identity of the tested material and the experimental model. Cellular observations cannot establish effects in an intact organism or characterize a different formulation. Human reports concerning Epithalamin do not establish interchangeability with synthetic AEDG. Neither the peptide name nor a shared research theme is sufficient to bridge these distinctions.

Formulation note

The published research referenced in the source description primarily concerns other experimental materials and settings, including cell-culture AEDG and a distinct pineal extract, rather than this nasal spray formulation. Findings from injected or differently formulated material cannot be transferred to this nasal spray formulation. Differences in composition, experimental exposure and route require separate evidence; the catalogue format alone supplies none of that evidence.

Quality and testing

Quality information must be linked to a batch-specific certificate of analysis (CoA) matching this product, format, strength and lot. A report for peptide powder, another presentation or a similarly named extract is not a substitute. Confirm the documented identity, analyte content and formulation details against the matching CoA and safety data sheet (SDS).

Chromatographic area purity, peptide identity, analyte content, counter-ion content, sterility, endotoxin and elemental impurities are separate analytical measurements. A result for one does not establish the others. Only tests documented in an available, matching batch report should be regarded as verified; the catalogue description does not certify unreported attributes.

Supplied exclusively for laboratory research by qualified professionals. Not for human or veterinary use. The nasal spray presentation does not confer medicinal authorization or human-use status.